Pediatric Clinical Trials Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Pediatric Clinical Trials Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Clinical trials are the gold standard and must for generating evidence-based data and knowledge in medicine. Clinical trials conducted on children (between age group of 0 to 18) for research and development of drugs or formation of new drugs are called as pediatric clinical trials. Pharmaceuticals and biotechnological industries and government regulatory bodies are collectively focused on improving research and development for pediatrics population. A new law in the U.S. and Europe was passed as pediatric regulation 2007 that required new adult drugs to be tested for use in children. This in turn is expected to lead to increasing number of pediatric clinical trials in the U.S. and worldwide.

Market Dynamics

Robust product pipeline, increasing approval of new pediatric drugs and high outsourcing for drug development are major factors driving pediatric clinical trials market growth. According to Pharmaceutical Research and Manufacturers’ Association (PHRMA) data in 2018, over 1,300 industry-sponsored pediatric clinical trials are underway across a variety of therapeutic areas, including diseases where there is significant unmet need such as infectious diseases, neurologic conditions, genetic disorders, and several forms of cancer. Similarly, 5 pediatric drugs received U.S. FDA approvals in 2018 and 4 and 7 in 2017 and 2015, respectively.

Moreover, introduction of new approaches in clinical research and implementation of advanced technology is expected to boost the market growth. Adoption of data analytics and machine learning platforms is expected to help in better management of the data generated during trials, which can play key role in faster drug development. For instance, in 2015, Quintiles announced the addition of advanced statistical monitoring and predictive analytics capabilities to its risk-based monitoring (RBM) solution.

Key features of the study:

  • This report provides in-depth analysis of the pediatric clinical trials market, provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global pediatric clinical trials market based on the following parameters–company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Syneos Health Inc., IQVIA Holdings, Inc., Charles River Laboratories International Inc., Covance Inc., ICON plc., Pharmaceutical Product Development, LLC, Genentech (F. Hoffmann-La Roche AG), Pfizer, Inc., Bristol - Myers Squibb, GlaxoSmithKline plc., Sanofi S.A., Novartis AG, Johnson & Johnson, Merck & Co., Inc., Shire plc., and Vertex Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global pediatric clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the pediatric clinical trials market
Detailed Segmentation:
  • Global Pediatric Clinical Trials Market, By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • Global Pediatric Clinical Trials Market, By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • Global Pediatric Clinical Trials Market, By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • Global Pediatric Clinical Trials Market, By Region:
  • North America
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Clinical Trial Phase:
  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • By Study Design:
  • Interventional
  • Randomized Trial
  • Non-randomized Trial
  • Crossover Trial
  • Observational
  • By Medical Condition:
  • Neuropsychiatric Conditions
  • Infectious Diseases
  • Maternal and Perinatal Conditions
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Cancer
  • Digestive Diseases
  • Diabetes
  • Nutritional Deficiencies
  • Others
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Syneos Health Inc. *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • IQVIA Holdings, Inc.
  • Charles River Laboratories International Inc.
  • Covance Inc.
  • ICON plc.
  • Pharmaceutical Product Development, LLC.
  • Genentech (F. Hoffmann-La Roche AG).
  • Pfizer, Inc.
  • Bristol - Myers Squibb.
  • GlaxoSmithKline plc.
  • Sanofi S.A.
  • Novartis AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Shire plc.
  • Vertex Pharmaceuticals Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Clinical Trial Phase
Market Snippet, By Study Design
Market Snippet, By Medical Condition
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Impact Analysis
Market Opportunities
Collaborators For Pediatric Trial Network Studies
Incentives To Promote Pediatric Trial
Regulatory Scenario
Total Number Of Trials In the U.S. and Europe
List Of Pediatric Trials Registered In The U.S. (2018)
List Of Pediatric Trials Registered In Europe (2015-2018)
Overview Of Pediatric Trials Network (PTN) And List Of Trials Registered Under PTN
4. Global Pediatric Clinical Trials Market, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017– 2026
Segment Trends
Phase-I
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Phase-II
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Phase-III
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
5. Global Pediatric Clinical Trials Market, By Study Design, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017– 2026
Segment Trends
Interventional
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
• Randomized Trial
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
• Non-randomized Trial
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
• Cross-over Trial
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Observational
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
6. Global Pediatric Clinical Trials Market, By Medical Condition, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017– 2026
Segment Trends
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Maternal and Perinatal Conditions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Respiratory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Digestive Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Nutritional Deficiencies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Mn)
7. Global Pediatric Clinical Trials Market, By Region, 2018 – 2026, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, For Regions, 2017–2026
North America
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Clinical Trial Phase, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Study Design, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Medical Condition, 2018 – 2026, (US$ Mn)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Syneos Health Inc.*
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
IQVIA Holdings, Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Charles River Laboratories International Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Covance Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
ICON plc
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Pharmaceutical Product Development, LLC
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Genentech (F. Hoffmann-La Roche AG)
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Pfizer, Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Bristol - Myers Squibb
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
GlaxoSmithKline plc
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi S.A.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Novartis AG
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Merck & Co., Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Shire plc
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Vertex Pharmaceuticals Inc.
Company Overview
Clinical Trial Phase Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 38 market data tables and 34 figures on "Pediatric Clinical Trials Market - Global forecast to 2026”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook